{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T22:10:10Z","timestamp":1721167810593},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s12282-019-00971-6","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T17:04:13Z","timestamp":1555088653000},"page":"846-851","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers"],"prefix":"10.1007","volume":"26","author":[{"given":"Satoko","family":"Shimada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Gomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Horii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayoko","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuumi","family":"Ashihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuho","family":"Kita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Futoshi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsue","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,12]]},"reference":[{"key":"971_CR1","unstructured":"National Comprehensive Cancer Network. NCCN guidelines. http:\/\/www.nccn.org\/professionals\/physician_gls\/ . Accessed 19 Dec 2017."},{"key":"971_CR2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s12282-016-0673-8","volume":"23","author":"N Taira","year":"2016","unstructured":"Taira N, Arai M, Ikeda M, Iwasaki M, Okamura H, Takamatsu K, et al. The Japanese Breast Cancer Society clinical practice guideline for epidemiology and prevention of breast cancer, 2015 edition. Breast Cancer. 2016;23:343\u201356.","journal-title":"Breast Cancer"},{"key":"971_CR3","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1200\/JCO.2009.27.0835","volume":"29","author":"E Warner","year":"2011","unstructured":"Warner E, Hill K, Causer P, Plewes D, Jong R, Yaffe M, et al. Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J Clin Oncol. 2011;29:1664\u20139.","journal-title":"J Clin Oncol"},{"key":"971_CR4","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","volume":"292","author":"E Warner","year":"2004","unstructured":"Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA. 2004;292:1317\u201325.","journal-title":"JAMA"},{"key":"971_CR5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2214\/AJR.13.12264","volume":"204","author":"A Raikhlin","year":"2015","unstructured":"Raikhlin A, Curpen B, Warner E, Betel C, Wright B, Jong R. Breast MRI as an adjunct to mammography for breast cancer screening in high-risk patients: retrospective review. AJR Am J Roentgenol. 2015;204:889\u201397.","journal-title":"AJR Am J Roentgenol"},{"key":"971_CR6","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1200\/JCO.2014.56.8626","volume":"33","author":"CC Riedl","year":"2015","unstructured":"Riedl CC, Luft C, Bernhart C, Weber M, Bernathova M, Tea MK, et al. Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol. 2015;33:1128\u201335.","journal-title":"J Clin Oncol"},{"key":"971_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/1055-9965.EPI-11-0775","volume":"21","author":"N Mavaddat","year":"2012","unstructured":"Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, et al. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1\/2 (CIMBA). Cancer Epidemiol Biomark Prev. 2012;21:134\u201347.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"971_CR8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10549-017-4332-3","volume":"165","author":"A Liede","year":"2017","unstructured":"Liede A, Mansfield CA, Metcalfe KA, Price MA, Snyder C, Lynch HT, et al. Preferences for breast cancer risk reduction among BRCA1\/BRCA2 mutation carriers: a discrete-choice experiment. Breast Cancer Res Treat. 2017;165:433\u201344.","journal-title":"Breast Cancer Res Treat"},{"key":"971_CR9","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ijc.29032","volume":"136","author":"BA Heemskerk-Gerritsen","year":"2015","unstructured":"Heemskerk-Gerritsen BA, Rookus MA, Aalfs CM, Ausems MG, Coll\u00e9e JM, Jansen L, et al. Improved overall survival after contralateral risk-reducing mastectomy in BRCA1\/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis. Int J Cancer. 2015;136:668\u201377.","journal-title":"Int J Cancer"},{"key":"971_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10549-013-2583-1","volume":"140","author":"DGR Evans","year":"2013","unstructured":"Evans DGR, Ingham SL, Baildam A, Ross GL, Lalloo F, Buchan I, et al. Contralateral mastectomy improves survival in women with BRCA1\/2-associated breast cancer. Breast Cancer Res Treat. 2013;140:135\u201342.","journal-title":"Breast Cancer Res Treat"},{"key":"971_CR11","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1097\/SLA.0000000000000769","volume":"260","author":"OM Fayanju","year":"2014","unstructured":"Fayanju OM, Stoll CRT, Fowler S, Colditz GA, Margenthaler JA. Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis. Ann Surg. 2014;260:1000\u201310.","journal-title":"Ann Surg"},{"key":"971_CR12","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1200\/JCO.2011.39.3645","volume":"30","author":"V Vichapat","year":"2012","unstructured":"Vichapat V, Garmo H, Holmqvist M, Liljegren G, W\u00e4rnberg F, Lambe M, et al. Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study. J Clin Oncol. 2012;30:3478\u201385.","journal-title":"J Clin Oncol"},{"key":"971_CR13","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","volume":"22","author":"TR Rebbeck","year":"2004","unstructured":"Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, Van\u2019t Veer L, Garber JE, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol. 2004;22:1055\u201362.","journal-title":"J Clin Oncol"},{"key":"971_CR14","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1245\/s10434-015-4532-1","volume":"22","author":"F Felice De","year":"2015","unstructured":"De Felice F, Marchetti C, Musella A, Palaia I, Perniola G, Musio D, et al. Bilateral risk-reduction mastectomy in BRCA1 and BRCA2 mutation carriers: a meta-analysis. Ann Surg Oncol. 2015;22:2876\u201380.","journal-title":"Ann Surg Oncol"},{"key":"971_CR15","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1399-0004.2010.01604.x","volume":"79","author":"AB Skytte","year":"2011","unstructured":"Skytte AB, Cr\u00fcger D, Gerster M, L\u00e6nkholm AV, Lang C, Br\u00f8ndum-Nielsen K, et al. Breast cancer after bilateral risk-reducing mastectomy. Clin Genet. 2011;79:431\u20137.","journal-title":"Clin Genet"},{"key":"971_CR16","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s10549-013-2765-x","volume":"142","author":"SL Ingham","year":"2013","unstructured":"Ingham SL, Sperrin M, Baildam A, Ross GL, Clayton R, Lalloo F, et al. Risk-reducing surgery increases survival in BRCA1\/2 mutation carriers unaffected at time of family referral. Breast Cancer Res Treat. 2013;142:611\u20138.","journal-title":"Breast Cancer Res Treat"},{"key":"971_CR17","doi-asserted-by":"publisher","first-page":"g226","DOI":"10.1136\/bmj.g226","volume":"348","author":"K Metcalfe","year":"2014","unstructured":"Metcalfe K, Gershman S, Ghadirian P, Lynch HT, Snyder C, Tung N, et al. Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis. BMJ. 2014;348:g226.","journal-title":"BMJ"},{"key":"971_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1200\/JCO.2015.62.3942","volume":"34","author":"AJ Broek van den","year":"2016","unstructured":"van den Broek AJ, Van\u2019t Veer LJ, Hooning MJ, Cornelissen S, Broeks A, Rutgers EJ, et al. Impact of age at primary breast cancer on contralateral breast cancer risk in BRCA1\/2 mutation carriers. J Clin Oncol. 2016;34:409\u201318.","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-019-00971-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12282-019-00971-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-019-00971-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T21:43:27Z","timestamp":1721166207000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12282-019-00971-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["971"],"URL":"https:\/\/doi.org\/10.1007\/s12282-019-00971-6","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,12]]},"assertion":[{"value":"14 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There are no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}